4.7 Article

Thiol Isomerases Orchestrate Thrombosis and Hemostasis

期刊

ANTIOXIDANTS & REDOX SIGNALING
卷 35, 期 13, 页码 1116-1133

出版社

MARY ANN LIEBERT, INC
DOI: 10.1089/ars.2021.0086

关键词

protein disulfide isomerase; platelet; thrombosis; thiol isomerase; history; inhibitors

资金

  1. British Heart Foundation [RG/15/2/31224]
  2. Medical Research Council [MR/J002666/1]

向作者/读者索取更多资源

Protein disulfide isomerase (PDI) and sibling proteins play essential roles in thrombus formation by influencing protein folding and function at the cell surface. Thiol isomerase targets have been identified, demonstrating their significance in regulating thrombosis.
Significance: Since protein disulfide isomerase (PDI) was first described in 1963, researchers have shown conclusively that PDI and sibling proteins are quintessential for thrombus formation. PDI, endoplasmic reticulum protein (ERp)5, ERp57, and ERp72 are released from platelets and vascular cells and interact with integrin alpha IIb beta 3 on the outer surface of platelets. Recent Advances: At the cell surface they influence protein folding and function, propagating thrombosis and maintaining hemostasis. TMX1, which is a transmembrane thiol isomerase, is the first family member shown to negatively regulate platelets. Targets of thiol isomerases have been identified, including integrin alpha 2 beta 1, Von Willebrand Factor, GpIb alpha, nicotinamide adenine dinucleotide phosphate oxidase (Nox)-1, Nox-2, and tissue factor, all of which are pro-thrombotic, and several of which are on the cell surface. In spite of this, PDI can paradoxically catalyze the delivery of nitric oxide to platelets, which decrease thrombus formation. Critical Issues: Although the overall effect of PDI is to positively regulate platelet activation, it is still unclear how thiol isomerases function in pro-thrombotic states, such as obesity, diabetes, and cancer. In parallel, there has been a surge in the development of novel thiol isomerase inhibitors, which display selectivity, potency and modulate thrombosis and hemostasis. The availability of selective thiol isomerase inhibitors has culminated in clinical trials, with promising outcomes for the prevention of cancer-associated thrombosis. Future Directions: Altogether, thiol isomerases are perceived as an orchestrating force that regulates thrombus development. In the current review, we will explore the history of PDI in cardiovascular biology, detail known mechanisms of action, and summarize known thiol isomerase inhibitors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据